W. Abou-Chedid

Royal Surrey NHS Foundation Trust

Papers

2

Total Citations

8

H-Index

2

About

W. Abou-Chedid is a clinical researcher specializing in surgical oncology and healthcare delivery, with a focused interest in the impact of public health crises on cancer care. Their major contributions center on analyzing how the COVID-19 pandemic disrupted oncology services, particularly in high-volume surgical settings. In their 2021 study on surgical volume and training at a pelvic oncology centre, Abou-Chedid documented how the pandemic led to significant deferrals of surgeries and diagnostic delays, highlighting the collateral damage to cancer patients beyond the virus itself. This work, along with their companion paper on delivering safe and timely cancer care during the transition period, has garnered attention for its practical insights into maintaining oncological standards amidst crisis. Though early in their career, with each paper cited 4 times, these studies serve as critical documentation for health systems planning future pandemic responses. Abou-Chedid’s research underscores the importance of balancing infection control with uninterrupted cancer treatment, offering lessons for surgical training programs and hospital administrators navigating similar disruptions.

Research Focus

Key Achievements

2
H-Index
2
Papers
8
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Delivering safe and timely cancer care during COVID‐19: lessons and successes from the transition period
4 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Royal Surrey NHS Foundation Trust

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago